Category: CV Sciences

FDA Public Hearing About CBDs Prescribes Caution, Bearishness, and Deliberation

Last Friday, the U.S. Food and Drug Administration (FDA) held its first public hearing about the safety and regulation of cannabis and cannabis-derived products. At the heart of the hearing were issues of how the FDA should...

Read More